nach oben

Journal of Neurology

Erschienen in:

27.11.2019 | Original Communication

Leber hereditary optic neuropathy plus dystonia, and transverse myelitis due to double mutations in MT-ND4 and MT-ND6

verfasst von: Andres Berardo, Valentina Emmanuele, Wendy Vargas, Kurenai Tanji, Ali Naini, Michio Hirano

Erschienen in: Journal of Neurology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Leber hereditary optic neuropathy (LHON) typically presents as painless central or centrocecal scotoma and is due to maternally inherited mitochondrial DNA (mtDNA) mutations. Over 95% of LHON cases are caused by one of three mtDNA “common” point mutations: m.3460G>A, m.11778G>A, or m.14484T>C, which are all in genes encoding structural subunits of complex I of the respiratory chain. Intriguing features of LHON include: incomplete penetrance, tissue specificity, and male predominance, indicating that additional genetic or environmental factors are modulating the phenotypic expression of the pathogenic mtDNA mutations. However, since its original description as a purely ophthalmological disorder, LHON has also been linked to multisystemic conditions with variable neurological, cardiac, and skeletal abnormalities. Although double “common” mutations have been reported to cause LHON and LHON-plus, they are extremely rare. Here, we present a patient with an unusual double point mutation (m.11778 G>A and m.14484T>C) with a multisystemic LHON-plus phenotype characterized by: optic neuropathy, ptosis, ataxia, dystonia, dysarthria, and recurrent extensive transverse myelitis.

Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430PubMed

Man PYW, Griffiths PG, Hudson G, Chinnery PF (2009) Inherited mitochondrial optic neuropathies. J Med Genet 46:145–158

Carelli V, La Morgia C, Valentino ML, Barboni P, Ross-Cisneros FN, Sadun AA (2009) Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. BiochimBiophysActa 1787:518–528

Brown MD, Torroni A, Reckord LC, Wallace DC (1995) Phylogenetic analysis of Leber’s hereditary optic neuropathy mitochondrial DNA’s indicates multiple independent occurrences of the common mutations. Hum Mutat 6:311–325PubMed

Carelli V, Ross-Cisneros F, Sadun A (2004) Mitochondrial dysfunction as a cause of optic neuropathies. ProgRetin Eye Res 23:53–89

Chinnery PF, Brown DT, Andrews RM, Singh-Kler R, Riordan-Eva P, Lindley J, Applegarth DA, Turnbull DM, Howell N (2001) The mitochondrial ND6 gene is a hot spot for mutations that cause Leber’s hereditary optic neuropathy. Brain 124:209–218PubMed

Valentino ML, Avoni P, Barboni P, Pallotti F, Rengo C, Torroni A, Bellan M, Baruzzi A, Carelli V (2002) Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber’s hereditary optic neuropathy. Ann Neurol 51:774–778PubMed

von Graefe A (1858) Einungewoehnlicherfall von hereditaerer Amaurose [An unusual case of hereditary amaurosis]. Arch f Ophthalmol 4:266–268

Leber T (1871) Ueberhereditäre und congenital angelegte Sehnervenleiden [On hereditary and congenital optic nerves]. Arch f Ophthalmol. 17:249–291

10.

Caporali L, Maresca A, Capristo M, Del Dotto V, Tagliavini F, Valentino ML, La Morgia C, Carelli V (2017) Incomplete penetrance in mitocondrial optic neuropathies. Mitochondrion 36:130–137PubMed

11.

Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN et al (2011) Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 134:220–234PubMed

12.

Giordano L, Deceglie S, d'Adamo P, Valentino ML, La Morgia C, Fracasso F, Roberti M, Cappellari M et al (2015) Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis 6:e2021. https://doi.org/10.1038/cddis.2015.364 CrossRefPubMedPubMedCentral

13.

Brown MD, Starikovskaya E, Derbeneva O, Hosseini S, Allen JC, Mikhailovskaya IE, Sukernik RI, Wallace DC (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup. J. Hum Genet 110:130–138

14.

Wallace DC (1970) A new manifestation of Leber’s disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain 93:121–132PubMed

15.

Jun AS, Brown MD, Wallace DC (1994) A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 91:6206–6210PubMed

16.

Kim IS, Ki CS, Park KJ (2010) Pediatric-onset dystonia associated with bilateral striatal necrosis and G14459A mutation in a Korean family: a case report. J Korean Med Sci 25:180–184PubMed

17.

Pfeffer G, Burke A, Yu-Wai-Man PD, Compston A, Chinnery P (2013) Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology 81:2073–2081PubMedPubMedCentral

18.

Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P, Savontaus ML (1995) Leber's"plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 59:160–164PubMedPubMedCentral

19.

McClelland CM, Van Stavern GP, Tselis AC (2011) Leber hereditary optic neuropathy mimicking neuromyelitis optica. J Neuroophthalmol 31:265–268PubMed

20.

Ghezzi A, Baldini S, Zaffaroni M, Leoni G, Koudriavtseva T, Casini AR, Zeviani M (2004) Devic’s neuromyelitis optica and mitochondrial DNA mutation: a case report. Neurol Sci 25:S380–S382PubMed

21.

Howell N, Miller NR, Mackey DA, Arnold A, Herrnstadt C, Williams IM, Kubacka I (2002) Lightning strikes twice: Leber hereditary optic neuropathy families with two pathogenic mtDNA mutations. J Neuroophthalmol 22:262–269PubMed

22.

Bursle C, Riney K, Stringer J, Moore D, Gole G, Kearns LS, Mackey DA, Coman D (2017) Leber hereditary optic neuropathy and longitudinally extensive transverse myelitis. JIMD Rep. https://doi.org/10.1007/8904_2017_79 CrossRefPubMedPubMedCentral

23.

Harding AE, Sweeney MG, Miller DH et al (1992) Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain 115:979–989PubMed

24.

Paulus W, Straube A, Bauer W, Harding AE (1993) Central nervous system involvement in Leber’s optic neuropathy. J Neurol 240:251–253PubMed

25.

La Russa A, Cittadella R, Andreoli V, Valentino P, Trecroci F, Caracciolo M, Gallo O, Gambardella A, Quattrone A (2011) Leber's hereditary optic neuropathy associated with a multiple-sclerosis-like picture in a man. Mult Scler 17:763–766PubMed

26.

Kovács GG, Höftberger R, Majtényi K, Horváth R, Barsi P, Komoly S, Lassmann H, Budka H, Jakab G (2005) Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 128:35–41PubMed

27.

Perez F, Anne O, Debruxelles S, Menegon P, Lambrecq V, Lacombe D, Martin-Negrier ML, Brochet B, Goizet C (2009) Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg 111:83–86PubMed

28.

Shiraishi W, Hayashi S, Kamada T, Isobe N, Yamasaki R, Murai H, Ohyagi Y, Kira J (2014) A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy. Mult Scler 20:258–260PubMed

29.

Kovacs GG, Hoftberger R, Majtenyi K et al (2005) Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 128:35–41PubMed

30.

Jaros E, Mahad DJ, Hudson G, Birchall D, Sawcer SJ, Griffiths PG, Sunter J, Compston DA, Perry RH, Chinnery PF (2007) Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy. Neurology 69:214–216PubMed

31.

Novotny EJ, Singh G, Wallace DC, Dorfman LJ, Louis A, Sogg RL, Steinman L (1986) Leber's disease and dystonia: a mitochondrial disease. Neurology 36:1053–1060PubMed

32.

De Vries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RM, Bolhuis PA, van Oost BA (1996) Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 58:703–711PubMedPubMedCentral

33.

34.

Watanabe M, Mita S, Takita T, Goto Y, Uchino M, Imamura S (2006) Leber's hereditary optic neuropathy with dystonia in Japanese family. JNeurolSci 243:31–34

35.

Spruijt L, Smeets HJ, Hendrickx A, Bettink-Remeijer MW, Maat-Kievit A, Schoonderwoerd KC, Sluiter W, de Coo IF, Hintzen RQ (2007) A MELAS-associated ND1 mutation causing Leber hereditary optic neuropathy and spastic dystonia. Arch Neurol 64:890–893PubMed

36.

Wang K, Takahashi Y, Gao ZL, Wang GX, Chen XW, Goto J, Lou JN, Tsuji S (2009) Mitochondrial ND3 as the novel causative gene for Leber hereditary optic neuropathy and dystonia. Neurogenetics 10:337–345PubMed

37.

Kirby DM, McFarland R, Ohtake A, Dunning C, Ryan MT, Wilson C, Ketteridge D, Turnbull DM, Thorburn DR, Taylor RW (2004) Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet 41:784–789PubMedPubMedCentral

38.

Cruz-Bermúdez A, Vicente-Blanco RJ, Hernández-Sierra R, Montero M, Alvarez J, González Manrique M, Blázquez A, Martín MA et al (2016) Functional characterization of three concomitant mtDNA LHON mutations shows no synergistic effect on mitochondrial activity. PLoS ONE 11:e0146816PubMedPubMedCentral

39.

Smith PR, Cooper JM, Govan GG, Harding AE, Schapira AH (1994) Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 122:80–83PubMed

40.

Yu-Wai-Man P, Turnbull DM, Chinnery PF (2002) Leber hereditary optic neuropathy. J Med Genet 39:162–169PubMed

41.

Brown MD, Allen JC, Van Stavern GP, Newman NJ, Wallace DC (2001) Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 104:331–338PubMed

42.

Catarino CB, Ahting U, Gusic M, Iuso A, Repp B, Peters K, Biskup S, von Livonius B, Prokisch H, Klopstock T (2017) Characterization of a Leber's hereditary optic neuropathy (LHON) family harboring two primary LHON mutations m.11778G%3eA and m.14484T%3eC of the mitochondrial DNA. Mitochondrion 36:15–20PubMed

43.

Yu AK, Song L, Murray KD, van der List D, Sun C, Shen Y, Xia Z, Cortopassi GA (2015) Mitochondrial complex I deficiency leads to inflammation and retinal ganglion cell death in the Ndufs4 mouse. Hum Mol Genet 24:2848–2860PubMedPubMedCentral

44.

Yu AK, Datta S, McMackin MZ, Cortopassi GA (2017) Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules. Hum Mol Genet 26:4929–4936PubMedPubMedCentral

45.

Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE (1995) The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 118(Pt 2):319–337PubMed

Titel: Leber hereditary optic neuropathy plus dystonia, and transverse myelitis due to double mutations in MT-ND4 and MT-ND6
verfasst von: Andres Berardo
Valentina Emmanuele
Wendy Vargas
Kurenai Tanji
Ali Naini
Michio Hirano
Publikationsdatum: 27.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 3/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-019-09619-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Jiří Procháska (1749–1820)

Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis

Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature

Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study

Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation